HDGFL2 and malaria: Since the introduction of RDTs in the late 2000s, over 900 million RDTs have been used for malaria testing in Uganda, all of which were HRP2-based and targeted P. falciparum. As a result, HRP2-specific RDTs currently account for >80% of the total malaria tests in Uganda [6,10].